Edaravone
Back to searchMolecule Structure
Scientific Name
Edaravone
Description of the Drug
Edaravone is a free radical scavenger used to delay the progression of ALS.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB12243
http://www.drugbank.ca/drugs/DB12243
Brand Name(s)
Radicava, Radicava ors, Radicut
Company Owner(s)
Mitsubishi Tanabe Pharma Corp
Mechanism(s) Of Action
Not Available
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL4704 | |
Human Metabolome Database | HMDB0251697 | |
DrugBank | DB12243 | |
PubChem: Thomson Pharma | 15219562 | |
PubChem | 4021 | |
NMRShiftDB | 20097610 | |
LINCS | LSM-5486 | |
Nikkaji | J37.341I | |
PDBe | W1P | |
BindingDB | 50200541 | |
EPA CompTox Dashboard | DTXSID9021130 | |
DrugCentral | 4156 | |
Brenda | 169637 | |
ChemicalBook | CB1287462 | CB02130134 |
rxnorm | EDARAVONE | RADICAVA |
PubChem: Drugs of the Future | 12014003 | |
KEGG Ligand | C13008 | |
ChEBI | 31530 | |
ZINC | ZINC000018203737 |